Latest Breaking News On - Artax science - Page 1 : comparemela.com

Artax Biopharma Appoints Andre Hoekema, Ph D , to Company s Board of Directors

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today.

United kingdomAndre hoekemaArtax biopharmaJoseph lobackiCompany board of directorsGenentech incLeiden universityPrnewswire artax biopharma incInvitrogen corporationLife sciencesCorporate development europeCompany welcomes drCompany mergers acquisitionsBusiness developmentBiotech veteranTrack record

Artax Biopharma Expands Company s Scientific Advisory Board

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today.

Stanford universityUnited statesSan diegoUnited kingdomNoord hollandLawrence steinmanBatty jrArtax biopharmaBalbino alarcEli lillyJamesg kruegerD martin carterRaif gehaAjay nirulaD scott batty jrCox terhorst

Artax Biopharma Appoints D Scott Batty, Jr , M D as Chief Medical Officer

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today.

United kingdomGeorgetown universityDistrict of columbiaUnited statesWalter reed army medical centerArtax biopharmaD scott batty jrBristol myers squibbJoseph lobackiNational institute of diabetesArtax biopharma incNational institutes of healthOncology groupTissue transplant research centerLiver transplantation at georgetown university hospitalImmunarray ltd

Artax Biopharma Announces First-in-Human Dosing in Phase 1 Clinical Trial for AX-158, Company s First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today.

Artax biopharmaJoseph lobackiArtax biopharma chief executive officer josephArtax science

Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Lawrence steinmanArtax biopharmaJoseph lobackiStanford university zimmerman professor of neurologyStanford university zimmerman professorArtax scientific advisory boardBiopharma chief executive officer joseph lobackiArtax scienceலாரன்ஸ் ஸ்டெய்ன்மேன்ஸ்டான்போர்ட் பல்கலைக்கழகம் ஸிம்மர்மந் ப்ரொஃபெஸர் ஆஃப் நரம்பியல்ஸ்டான்போர்ட் பல்கலைக்கழகம் ஸிம்மர்மந் ப்ரொஃபெஸர்